beta
Trial Radar AI
One study matched filter criteria
Card View
Back to Search

Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy (DINE-GLP1) 50 Dietary

Recruiting
Clinical Trial NCT07313384 (DINE-GLP1) is an observational study for Obesity Type 2 Diabetes Mellitus, Obesity (Disorder) that is recruiting. It started on February 11, 2026 with plans to enroll 50 participants. Led by University of South Carolina, it is expected to complete by December 1, 2026. The latest data from ClinicalTrials.gov was last updated on February 19, 2026.
Brief Summary
The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since these medications reduce food intake, it's important to ensure the diet is nutritious even with fewer calories to help with...Show More
Official Title

Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy

Conditions
Obesity Type 2 Diabetes MellitusObesity (Disorder)
Other Study IDs
  • DINE-GLP1
  • 2371702-1
NCT ID Number
NCT07313384
Start Date (Actual)
2026-02-11
Last Update Posted
2026-02-19
Completion Date (Estimated)
2026-12-01
Enrollment (Estimated)
50
Study Type
Observational
Status
Recruiting
Keywords
GLP-1 Therapy
Nutrition Support
Obesity
Weight loss therapy
Arms / Interventions
Participant Group/ArmIntervention/Treatment
GLP-1 Therapy
Individuals prescribed with GLP-1 Therapy for obesity or T2DM management.
GLP-1 Therapy
Exposure to GLP-1 Therapy for obesity or T2DM management.
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Change in Healthy Eating Index
The Healthy Eating Index (HEI) is a scoring metric developed by the U.S. Department of Agriculture (USDA) and the NCI to assess how well a person's diet conforms to the Dietary Guidelines for Americans. It evaluates the consumption of 13 dietary components, including both adequacy (foods to increase) and moderation (foods to decrease). The scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations and dietary patterns published in the Dietary Guidelines.
Baseline and 12-weeks
Secondary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Change in Body Weight
Change from Baseline in Body Weight at 12-weeks
Baseline and 12 weeks
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
  • Adults aged 18 and older
  • Recently has been prescribed GLP-1 therapy for the treatment of obesity or T2DM but have not yet initiated the medication
  • Has regular access to a smartphone and internet to complete short surveys and food recalls online
  • Willing to sign informed consent.

  • Already began the GLP-1 medication
  • Have medical concerns making participation unsafe
University of South Carolina logoUniversity of South Carolina301 active studies to explore
Prisma Health-Upstate logoPrisma Health-Upstate
Study Responsible Party
Shiba Simon Bailey, Principal Investigator, Posdoctoral Fellow, University of South Carolina
No contact data.
2 Study Locations in 1 Countries

South Carolina

University South Carolina, Columbia, South Carolina, 20208, United States
Enrolling by invitation
Prisma Health Weight Management Institute, Greenville, South Carolina, 29607, United States
Abby Birrell, CCRC, Contact, 864-522-2117, [email protected]
John D Scott, MD, Contact, [email protected]
John D Scott, MD, Sub-Investigator
Patricia L Eichhorn, MD, Sub-Investigator
Eva M Wolf, MD, Sub-Investigator
Allyson Hale, PA, Sub-Investigator
Recruiting